Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
placeholder image: silhouette of female physician

Megan S. Lim, MD, PhD Physician

Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Dr. Lim is employed by Penn Medicine.

No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Clinical Specialties


  • Pathology and Laboratory Medicine

Programs & Centers:

Board Certification:

  • Pathology - Anatomic Pathology, 1993
  • Pathology - Hematology, 1999
  • Pathology - Molecular Genetic Pathology, 2003

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of Calgary
Residency: University of Calgary
Fellowship: National Cancer Institute


A. J. French Society, Local American Association for Cancer Research, National American Biologic Resources and Facilities, National American Society for Clinical Pathology, National American Society for Investigative Pathology, National American Society of Hematology, National Association for Molecular Pathology, International Canadian Association of Pathologists, National Children’s Oncology Group, International College of American Pathologists, National Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Peer Review Cancer Research Program (PRCRP)-Lymphoma (LYM), National Lymphoma Research Foundation, National Michigan Society of Pathologists, Local NIH Lymphoma and Leukemia Molecular Profiling Project Grant, National Royal College of Physicians and Surgeons of Canada, National Society for Hematopathology/European Association for Haemotopathology, International St. Baldrick's Foundation, National United States and Canadian Academy of Pathology, International

Hospital Affiliation

Dr. Lim is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Shereck E. Day NS, Awasthi A, Ayello J, Chu Y, McGuinn C, van de Ven C, Lim MS, Cairo MS.: Immunophenotypic, cytotoxic, proteomic and genomic, characterization of human cord blood vs. peripheral blood CD56Dlm NK cells. Innate Immun. : 2019.

Lim MS, Beyer T, Babayan A, Bergmann M, Brehme M, Buyx A, Czernin J, Egger G, Elenitoba-Johnson KSJ, Gückel B, Jačan A, Haslacher H, Hicks RJ, Kenner L, Langanke M, Mitterhauser M, Pichler BJ, Salih HR, Schibli R, Schultz S, Simecek J, Simon J, Soares MO, Stelzl U, Wadsak W, Zatloukal K, Zeitlinger M, and Hacker M.: Advancing biomarker development through convergent engagement. Summary Report of the 2nd International Danube Symposium on biomarker development, molecular imaging and applied diagnostics. Molecular Imaging and Biology. : 2019.

Rollan DCM, Lim MS, Elenitoba-Johnson KSJ.: Mass spectrometry and proteomics in hematology. Seminars in Hematology 56 (1): 52-57,2019.

Lim MS: PMBCL: a molecular diagnosis? Blood 132 (22): 2319-2320,2018.

Chu Y, Lee S, Shah T, Yin C, Barth M, Miles RR, Ayello J, Harrison L, Van de Ven C, Galandry P, Goldman SC, Lim MS, Hermiston M, McAllister-Luca LM, Giulino-Roth L, Perkins SL, Cairo MS.: Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation, in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model. Oncoimmunology 8 (1): 2018.

Fajgenbaum DC, Oksendhendler E, Casper C, Uldrick, T, Kurzrock R, Yoshizaki K, Nasta S, Rossi JF, Wong R, Simpson D, Sato Y, Terriou L, Ferrero S, Zinzani PL, Hoffman C, Goodman A, Krymskaya V, Elenitoba-Johnson KSJ, Lim MS, Chadburn A, Penmaraju N, Leitch H, Jaffe ES, Jayanthan R, Chandrasakan S, Lechowicz MJ, Ruth J, Greenway A, Stone K, Shilling D, Mukherjee S, Partridge HL, Pierson SK, Streetly M, Schey S, Munshi N, Ide M, Srkalovic G, Fossa A, Dispenzieri A, Voorhees P, van Rhee F.: International, evidence-based consensus treatment guidelines for the management of idiopathic multicentric Castleman disease. Blood : 2018.

168., Nam SJ, Kim S, Kwon D, Kim H, Kim S, Lee E, Kim TM, Heo KS, Park SH, Lim MS, Kim CW, Jeon YK.: Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system. Oncoimmunology 13 (7): 2018.

Van Arnam JS, Lim MS, Elenitoba-Johnson KSJ: Novel Insights into the pathogenesis of T-cell Lymphomas Blood 11 : 2018.

Bhatti M, Ippolito T, Mavis C, Gu J, Cairo MS, Lim MS, Hernandez-Ilizaliturri F, Barth MJ: Pre-clinical activity of targeting the PI3K/Akt/m TOR pathway in Burkitt lymphoma Oncotarget 9 (31): 21820-21830,2018.

Prokoph N, Larose H, Lim MS, Burke GAA, Turner SD.: Treatment options for paediatric anaplastic large cell lymphoma (ALCL): current standard and beyond. Cancers (Basel) 10 (4): 2018.

Academic Contact Info

Department of Pathology and Laboratory Medicine
Stellar Chance Office Suite 609C
422 Curie Blvd.

Philadelphia, PA 19104
Phone: (215) 898-4719
Patient appointments: 800-789-7366 (PENN)